BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21773845)

  • 21. 17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression.
    Vuong NH; Salah Salah O; Vanderhyden BC
    Sci Rep; 2017 Dec; 7(1):16702. PubMed ID: 29196616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The localization of estrogen receptor alpha and its function in the ovaries of postmenopausal women.
    Brodowska A; Laszczynska M; Starczewski A; Karakiewicz B; Brodowski J
    Folia Histochem Cytobiol; 2007; 45(4):325-30. PubMed ID: 18165170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of estradiol on the expression of angiogenic factors in epithelial ovarian cancer.
    Valladares M; Plaza-Parrochia F; Lépez M; López D; Gabler F; Gayan P; Selman A; Vega M; Romero C
    Histol Histopathol; 2017 Nov; 32(11):1187-1196. PubMed ID: 28116735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of methoxychlor and estradiol on cytochrome p450 enzymes in the mouse ovarian surface epithelium.
    Symonds DA; Miller KP; Tomic D; Flaws JA
    Toxicol Sci; 2006 Feb; 89(2):510-4. PubMed ID: 16280380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
    Treeck O; Pfeiler G; Mitter D; Lattrich C; Piendl G; Ortmann O
    J Endocrinol; 2007 Jun; 193(3):421-33. PubMed ID: 17535880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer.
    Ciucci A; Zannoni GF; Travaglia D; Petrillo M; Scambia G; Gallo D
    Gynecol Oncol; 2014 Feb; 132(2):351-9. PubMed ID: 24378878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia?
    Maines-Bandiera SL; Auersperg N
    Int J Gynecol Pathol; 1997 Jul; 16(3):250-5. PubMed ID: 9421091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early alterations in ovarian surface epithelial cells and induction of ovarian epithelial tumors triggered by loss of FSH receptor.
    Chen X; Aravindakshan J; Yang Y; Sairam MR
    Neoplasia; 2007 Jun; 9(6):521-31. PubMed ID: 17603635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche.
    Flesken-Nikitin A; Hwang CI; Cheng CY; Michurina TV; Enikolopov G; Nikitin AY
    Nature; 2013 Mar; 495(7440):241-5. PubMed ID: 23467088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells.
    Moll F; Katsaros D; Lazennec G; Hellio N; Roger P; Giacalone PL; Chalbos D; Maudelonde T; Rochefort H; Pujol P
    Oncogene; 2002 Feb; 21(7):1097-107. PubMed ID: 11850827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer.
    Parrott JA; Kim G; Skinner MK
    Biol Reprod; 2000 Jun; 62(6):1600-9. PubMed ID: 10819761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and action of keratinocyte growth factor (KGF) in normal ovarian surface epithelium and ovarian cancer.
    Parrott JA; Kim G; Mosher R; Skinner MK
    Mol Cell Endocrinol; 2000 Sep; 167(1-2):77-87. PubMed ID: 11000522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.
    Marchese S; Silva E
    PLoS One; 2012; 7(10):e45767. PubMed ID: 23056216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone receptor expression profile of low-grade serous ovarian cancers.
    Buttarelli M; Mascilini F; Zannoni GF; Ciucci A; Martinelli E; Filippetti F; Scambia G; Ferrandina G; Gallo D
    Gynecol Oncol; 2017 May; 145(2):352-360. PubMed ID: 28228232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human steroidogenic factor-1 (hSF-1) regulates progesterone biosynthesis and growth of ovarian surface epithelial cancer cells.
    Ramayya MS; Sheng M; Moroz K; Hill SM; Rowan BG
    J Steroid Biochem Mol Biol; 2010 Mar; 119(1-2):14-25. PubMed ID: 20045459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells.
    Kang SK; Choi KC; Tai CJ; Auersperg N; Leung PC
    Endocrinology; 2001 Feb; 142(2):580-8. PubMed ID: 11159828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous estrogen receptor beta is transcriptionally active in primary ovarian cells from estrogen receptor knockout mice.
    Mueller SO; Katzenellenbogen JA; Korach KS
    Steroids; 2004 Sep; 69(10):681-6. PubMed ID: 15465114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel shift in estrogen receptor expression occurs as estradiol suppresses inflammation-associated colon tumor formation.
    Armstrong CM; Billimek AR; Allred KF; Sturino JM; Weeks BR; Allred CD
    Endocr Relat Cancer; 2013 Aug; 20(4):515-25. PubMed ID: 23702470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer.
    Parrott JA; Skinner MK
    Biol Reprod; 2000 Mar; 62(3):491-500. PubMed ID: 10684788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells.
    Cheung LW; Au SC; Cheung AN; Ngan HY; Tombran-Tink J; Auersperg N; Wong AS
    Endocrinology; 2006 Sep; 147(9):4179-91. PubMed ID: 16777976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.